UnitedHealth Group Incorporated (UNH) is set to report fourth-quarter 2024 results on Jan. 16, 2025, before the opening bell. The Zacks Consensus Estimate for the to-be-reported quarter’s earnings is currently pegged at $6.72 per shareon revenues of $102.25 billion. Stay up-to-date with all quarterly releases: See Zacks Earnings Calendar.Fourth-quarter earnings estimates have been revised downward by a penny over the past seven days. However, the bottom-line projection indicates an increase of 9.1% from the ...

As UnitedHealth Group executives continue to mourn the death of one of the healthcare giant’s top ... [+] executives, the company is bracing for reaction to what is likely another multi-billion-dollar profit for 2024 and the fourth quarter of last year. The company reports earnings on Thursday, January 16, 2025. In this photo is a general view outside the United Healthcare corporate headquarters on December 4, 2024 in Minnetonka, Minnesota. (Photo by Stephen Maturen/Getty Images)Getty ImagesAs UnitedHealth ...

If you are looking for a stock that has a solid history of beating earnings estimates and is in a good position to maintain the trend in its next quarterly report, you should consider UnitedHealth Group (UNH) . This company, which is in the Zacks Medical - HMOs industry, shows potential for another earnings beat.This largest U.S. health insurer has seen a nice streak of beating earnings estimates, especially when looking at the previous two reports. The average surprise for the last two quarters was 2.05%.F ...

Earnings Release - UnitedHealth Group Incorporated (NYSE: UNH) is scheduled to release its fourth-quarter earnings results on Thursday, January 16th [1] - The street expects the company's quarterly revenue to increase to $101.76 billion [1] - The street expects the company's earnings-per-share to decrease to $6.26 [1]

UnitedHealth Group Incorporated UNH will release earnings results for its fourth quarter, before the opening bell on Thursday, Jan. 16, 2025.Analysts expect the Minnetonka, Minnesota-based company to report quarterly earnings at $6.75 per share, up from $6.16 per share in the year-ago period. UnitedHealth projects to report revenue of $101.72 billion for the recent quarter, compared to $94.43 billion a year earlier, according to data from Benzinga Pro.Amedisys Inc AMED recently announced it extended its mer ...

UnitedHealth Group Incorporated (UNH) and Amedisys, Inc. (AMED) have reportedly decided to cancel their plan to sell medical centers to Texas-based VitalCaring Group, a move initially intended to address antitrust concerns related to their $3.3 billion merger. This sale was part of an effort to gain regulatory approval for the merger between Amedisys and UNH’s subsidiary, Optum.In November, the U.S. Department of Justice filed an antitrust lawsuit, arguing that the merger would give UnitedHealth too much co ...

In the latest market close, UnitedHealth Group (UNH) reached $513.67, with a +0.13% movement compared to the previous day. The stock trailed the S&P 500, which registered a daily gain of 0.55%. Meanwhile, the Dow experienced a drop of 0.06%, and the technology-dominated Nasdaq saw an increase of 1.24%.The investment community will be paying close attention to the earnings performance of UnitedHealth Group in its upcoming release. The company is slated to reveal its earnings on January 16, 2025. It is antici ...

Shares of UnitedHealth Group (UNH 1.61%) were pulling back in December due to a backlash against the company following the murder of one of its executives and reports of a potential crackdown on pharmacy benefit managers (PBMs), including UnitedHealth's OptumRx.Other media reports also shone a harsh light on the business and could lead to more regulation or an overhaul of some healthcare industry practices.According to data from S&P Global Market Intelligence, the stock lost 17% last month. As you can see f ...

Core Viewpoint - UnitedHealth Group is facing significant challenges due to recent events, including the tragic death of its insurance segment CEO, which has led to a stock decline of over 15% since early December [1]. Despite this, the company maintains strong fundamentals and growth potential in the healthcare sector [2][19]. Financial Performance - UnitedHealth Group has an AA- credit rating, indicating a strong financial position within investment-grade territory. The company generates billions in cash flow, which supports a growing dividend and share repurchase program [3]. - The company is projected to earn approximately $29.50 to $30 per share (non-GAAP) in 2025, resulting in a forward P/E ratio of 17. The anticipated earnings growth rate suggests a PEG ratio of 1.1 to 1.3, indicating good value [11][17]. Industry Context - The U.S. healthcare system is a massive industry, with expenditures totaling $4.9 trillion in 2023, equating to $14,570 per American. UnitedHealth Group is a central player, generating over $389 billion in annual revenue [6]. - The healthcare sector is politically sensitive, with rising costs leading to increased scrutiny and potential legislative changes that could impact companies like UnitedHealth Group [4][5]. Competitive Position - UnitedHealth Group's size provides it with leverage over customers and a competitive edge, contributing to its long-term growth. Historically, a $100 investment in the company has grown to over $447,000 [8]. - The company operates through two main business units: UnitedHealthcare and Optum, making it a pervasive entity in the healthcare industry [13]. Growth Outlook - Management forecasts long-term annualized earnings growth of 13% to 16%, reflecting the company's ongoing expansion and profitability [14]. - Despite regulatory threats, the company is viewed as fundamentally strong with clear competitive advantages, making it an attractive investment opportunity [19].

Industry Overview - The top health insurers have maintained a medical care ratio (MCR) between 82% and 84% for the better part of the last decade [3] - The seven largest publicly traded health insurers are projected to have an annual MCR of nearly 86% for 2024 [10] - Rising medical loss ratios in 2024 were modestly offset by lower administrative ratios and stronger investment income due to higher market interest rates [8] - Business diversification among some health insurers in terms of insurance products, provider assets, and pharmacy benefit management operations continues to soften the impact of elevated healthcare utilization [8] Medicaid and Medicare Challenges - Medicaid margin pressure could persist into the first half of 2025, with concerns about inadequate rates paid per Medicaid beneficiary relative to the average costs of care [2] - Health insurers face challenges in government-funded businesses, including Medicaid coverage for poor Americans and Medicare Advantage benefits for Americans 65 and older [5] - Pricing pressures from state Medicaid programs come as health insurers see increased costs from Americans getting more care post-Covid-19 pandemic [6] - Weaker combined operating performance for the largest seven publicly traded health insurers in the first nine months of 2024 reflected continued increases in healthcare service utilization in the senior population and higher acuity in the remaining Medicaid population [7] UnitedHealth Group Specifics - UnitedHealth Group faces rising costs and tough negotiations with governments it works with to provide health benefits to elderly and poor Americans [1][9] - UnitedHealthcare's medical care ratio was 85.2% for the third quarter of 2024 compared to 82.3% last year [10] - Companies like UnitedHealth Group, Humana, and CVS Health have large and growing businesses that also provide medical care, which could blunt some of the impact of rising costs in their health insurance businesses [4]